Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.

Interim results of two open-label extension studies assessed ezogabine/retigabine safety and tolerability for partial-onset seizures. At data cutoff, 336 (60%) patients received ≥ 12 months' open-label ezogabine/retigabine. The most common TEAEs included dizziness (22%), somnolence (19%), headache (14%), and fatigue (10%).

A comparison of gravid and under-house CO2-baited CDC light traps for mosquito species of public health importance in Houston, Texas.

The relative efficacy of gravid and under-house CO2 traps for monitoring mosquito species of public health importance within the Houston metroplex area was assessed. Gravid and under-house traps were colocated at 10 sites and monitored weekly between 1 March to 31 May 2007. The most numerous species caught was Culex pipiens quinquefasciatus Say.